Inflammatory disorders

Research provides new hope for those suffering from Crohn's disease

Researchers from the Hotchkiss Brain Institute (HBI) and the Snyder Institute for Chronic Diseases at the University of Calgary's Faculty of Medicine have discovered a pathway that may contribute to the symptoms related to ...

Diseases, Conditions, Syndromes

Pirfenidone: Extent of added benefit assessed

Pirfenidone inhibits the development of inflammation and scarring (fibrosis) in pulmonary tissue and has been approved for the treatment of mild to moderate idiopathic pulmonary fibrosis (IPF) since the beginning of 2011. ...

page 4 from 5